CHD5 and breast carcinoma: The methylation status of the CHD5 promoter region from -841 to -246, which contains 58 CpG sites and is frequently methylated in neuroblastoma cell lines [7], was determined in 9 breast cancer cell lines, 30 primary tumors, and 10 normal breast tissues.